Topical Delivery of Human Single-Domain Antibodies Targeting IL-33 Shows Potential to Treat Mucosal Inflammation 11·06·2025
BioAge Expands Metabolic Disease Pipeline with Nanobody-Based APJ Agonist from JiKang Therapeutics 05·06·2025